Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation - PRIME Study

NCT07653269 is registered in ClinicalTrials.gov with Singapore National Eye Centre as lead sponsor.

NCT NCT07653269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07653269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation - PRIME Study
Lead sponsor
Singapore National Eye Centre
Phase
Observational
Overall status
Recruiting
Start date
October 18, 2025
Completion date
July 31, 2029
Enrollment
1,500 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

age related macular degeneration